• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化和肝细胞癌中的核仁组织区

Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.

作者信息

Jain R, Malhotra V, Kumar N, Sarin S K

机构信息

Department of Pathology, G.B. Pant Hospital, New Delhi, India.

出版信息

Trop Gastroenterol. 1998 Jul-Sep;19(3):100-1.

PMID:9828706
Abstract

The argyrophilic technique for staining proteins associated with nucleolar organizer regions (AgNOR's) was applied to 32 liver biopsy specimens. These included 10 normal livers, 10 cirrhosis, 10 hepatocellular carcinomas (HCC) and 2 cholangiocarcinomas. The range of the mean number of NORs per nucleus was 1.3-1.7 (95% CI: 1.4-1.6) for normal liver, 2.4-3.5 (2.8-3.2) for cirrhosis, 3.0-7.9 (3.7-5.6) for HCC and 4.0-4.2 (3.9-4.3) for cholangiocarcinoma. The difference observed was statistically significant. The AgNORs were small and discrete in normal and cirrhotic liver and relatively larger and scattered in distribution in HCC. These results indicate that both quantitative and qualitative analysis of AgNORs may be useful as an adjunct to routine haematoxylin and eosin stain to distinguish cirrhosis from HCC especially when the latter is well differentiated.

摘要

将用于染色与核仁组织区相关蛋白质的嗜银技术(AgNORs)应用于32例肝活检标本。这些标本包括10例正常肝脏、10例肝硬化、10例肝细胞癌(HCC)和2例胆管癌。正常肝脏每核NORs平均数范围为1.3 - 1.7(95%可信区间:1.4 - 1.6),肝硬化为2.4 - 3.5(2.8 - 3.2),HCC为3.0 - 7.9(3.7 - 5.6),胆管癌为4.0 - 4.2(3.9 - 4.3)。观察到的差异具有统计学意义。AgNORs在正常和肝硬化肝脏中较小且离散,而在HCC中相对较大且分布分散。这些结果表明,AgNORs的定量和定性分析作为常规苏木精和伊红染色的辅助手段,对于区分肝硬化和HCC可能是有用的,特别是当后者分化良好时。

相似文献

1
Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.肝硬化和肝细胞癌中的核仁组织区
Trop Gastroenterol. 1998 Jul-Sep;19(3):100-1.
2
AgNOR counts are not altered in alcoholic cirrhosis.
Indian J Pathol Microbiol. 2003 Apr;46(2):170-2.
3
Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
Hepatology. 1995 Feb;21(2):393-7.
4
Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.一名患有丙型肝硬化且合并肝细胞癌的患者发生胆管癌腹膜内破裂。
Am J Gastroenterol. 1999 Aug;94(8):2320-1. doi: 10.1111/j.1572-0241.1999.2320a.x.
5
Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.起源于两个不同发育异常结节的同步性肝细胞癌和胆管癌。
Mod Pathol. 2002 Oct;15(10):1096-101. doi: 10.1097/01.MP.0000027622.74779.AE.
6
Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.合并肝细胞癌和胆管癌并伴有黏液癌成分,发生于肝硬化肝脏。
Pathol Int. 2006 Apr;56(4):222-6. doi: 10.1111/j.1440-1827.2006.01950.x.
7
Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.肝内胆管癌及肝细胞-胆管细胞癌合并症:西方经验
Ann Surg Oncol. 2008 Jul;15(7):1880-90. doi: 10.1245/s10434-008-9933-y. Epub 2008 Apr 29.
8
AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.血吸虫性肝硬化和肝细胞癌患者肝活检中AgNOR计数与DNA倍体分析
Clin Biochem. 2009 Nov;42(16-17):1616-20. doi: 10.1016/j.clinbiochem.2009.07.027. Epub 2009 Aug 12.
9
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].[肝细胞癌和胆管癌——不同的预后、发病机制及治疗]
Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195.
10
[Clinicopathologic features and diagnosis of mixed type hepatocellular carcinoma].[混合型肝细胞癌的临床病理特征与诊断]
Zhonghua Zhong Liu Za Zhi. 1995 May;17(3):208-11.